| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9336614 | Cancer Treatment Reviews | 2005 | 18 Pages |
Abstract
Over 540Â 000 patients worldwide have now received rituximab and serious adverse reactions have occurred in a small minority of patients, but for the great majority of patients, rituximab is safe and well tolerated.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Eva Kimby,